Chris Hassan
CEO, Soft Landing Recovery

Chris Hassan is the CEO of Soft Landing Recovery Centers. He is a Senior Healthcare Executive with over 25 years of experience in the field of healthcare. Prior to coming to Soft Landing, Chris co-founded Reckitt Beckiser Pharmaceuticals creating the office based treatment model for opioid dependence and launching Suboxone[R]. Subsequently, he served as the Chief Executive Officer of Colonial Management Group- the largest chain of opioid addiction treatment centers in the US at that time. He also developed and patented a number of new opioid product combinations focused on preventing diversion and inadvertent benzodiazepine overdose in patients. He is a committed father working to ensure that his children never have to suffer from the lack of effective treatment should they ever fall prey to this disease.